DeVito, Linda S
Participants self-reported general dietary habits, including changes in food preferences since the start of GLP-1RA therapy
And I think they will continue to do well as more people use GLP-1 drugs as one of the most common reported side effects is gastrointestinal distress. He added: My advice for a lot of brands wondering how to respond to new trends such as GLP-1s is instead of chasing them with new products, look at where your existing products can be positioned to tap into them
General practitioners are increasingly initiating these therapies, often in response to patient demand or as part of broader cardiometabolic risk management
Look for pharmacies that follow USP 797 and USP 800 sterile compounding standards, hold state board of pharmacy licensure, have PCAB accreditation (gold standard but not required), provide certificates of analysis for their products, and are transparent about their compounding processes
It did not establish an FDA-reviewed dose, treatment duration, route, contraindication list, interaction list, or monitoring plan
